Related Experiment Video
Updated: Jul 14, 2026

Doxycycline Loaded Collagen-Chitosan Composite Scaffold for the Accelerated Healing of Diabetic Wounds
Published on: August 21, 2021
Common ground?: Tetracyclines, matrix metalloproteinases, pustular dermatoses, and loxoscelism
1Vanderbilt University Medical Center, Nashville, Tennessee 37203, USA. lloyd.e.king@vanderbilt.edu
Abstract:
The fear of spiders is ancient and common throughout much of the world. Skin ulceration and necrosis due to Loxosceles spider envenomation ("bites") is among the best known sequelae of a usually accidental encounter. Therapies for Loxosceles envenomations either are not well documented or have adverse side effects that limit their use by generalists. Based on in vitro and in vivo studies in rabbits injected with purified or recombinant sphingomyelinase D2, Paixão-Cavalcante et al. (2007) propose in this issue that topical tetracyclines could become safe, efficacious therapy for cutaneous loxoscelism.
Insights
Topical tetracyclines show promise as a safe and effective treatment for Loxosceles spider bites, which cause skin necrosis. Further research supports their use for cutaneous loxoscelism.
Area of Science:
- Toxicology
- Dermatology
- Pharmacology
Background:
- Cutaneous loxoscelism, resulting from Loxosceles spider envenomation, presents a significant clinical challenge due to limited and potentially harmful treatment options.
- Existing therapies for Loxosceles envenomations are often poorly documented or associated with adverse effects, restricting their application by general medical practitioners.
Discussion:
- This research investigates the potential of topical tetracyclines as a therapeutic agent for cutaneous loxoscelism.
- The study is based on in vitro and in vivo experiments involving rabbits injected with purified or recombinant sphingomyelinase D2, a key enzyme in Loxosceles venom.
Key Insights:
- Topical tetracyclines demonstrate potential as a safe and efficacious treatment for skin ulceration and necrosis caused by Loxosceles spider envenomation.
- Sphingomyelinase D2 is identified as a critical factor in the pathogenesis of Loxosceles-induced tissue damage.
Outlook:
- Further clinical studies are warranted to validate the efficacy and safety of topical tetracyclines in human patients with cutaneous loxoscelism.
- The findings suggest a novel therapeutic strategy that could improve patient outcomes and broaden treatment accessibility for Loxosceles envenomations.
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Staphylococcal Skin Infections
Acne Infection
Clinical Significance of Antibiotic Resistance
Matrix Proteoglycans and Glycoproteins
Bacterial Phylum Tenericutes